Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers

作者: Maria Morganti , Monica Ciantelli , Beatrice Giglioni , Anna L. Putignano , Stefania Nobili

DOI: 10.1016/J.EJCA.2005.06.016

关键词: GeneCancer researchSNPGene expressionIntestinal mucosaGenotypePromoterThymidylate synthaseSingle-nucleotide polymorphismBiologyOncology

摘要: Thymidylate synthase (TS) intratumoural expression may be a prognostic marker and predict outcome of 5-fluorouracil (5-FU)-based chemotherapy in colorectal cancer patients. The TS gene promoter enhancer region contains two different polymorphisms which can influence mRNA transcriptional translational efficiency: polymorphic tandem repeat sequence (2 or 3 repeats; 2R 3R) single nucleotide polymorphism (SNP), G > C, within the second 3R alleles. We studied relationship between tumoural levels colonic mucosa 48 3R/3R genotype was characterised by higher tumour than 2R/2R-2R/3R genotypes (P = 0.071). Regarding with SNP polymorphism, statistically significant difference 3RG/3RG 2R/2R-2R/3RC-2R/3RG subset observed 0.017). No correlation experimental data baseline clinical-pathological characteristics as well clinical relatively small patient series investigated. This is first study reporting an association intra-repeat These results suggest that patients, C important factor determining levels, warrant further investigation role predictors sensitivity to 5-FU-based larger case series.

参考文章(33)
Zenro Nihei, Hiroyuki Uetake, Hiroyuki Yamada, Yoshinori Shirota, Kenichi Sugihara, Naoto Nishi, Wataru Ichikawa, Renzo Hirayama, Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Clinical Cancer Research. ,vol. 9, pp. 786- 791 ,(2003)
C G Leichman, H J Lenz, L Leichman, K Danenberg, J Baranda, S Groshen, W Boswell, R Metzger, M Tan, P V Danenberg, Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. Journal of Clinical Oncology. ,vol. 15, pp. 3223- 3229 ,(1997) , 10.1200/JCO.1997.15.10.3223
P G Johnston, E R Fisher, H E Rockette, B Fisher, N Wolmark, J C Drake, B A Chabner, C J Allegra, The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. Journal of Clinical Oncology. ,vol. 12, pp. 2640- 2647 ,(1994) , 10.1200/JCO.1994.12.12.2640
E Kanehira, K Omura, K Kawakami, Y Watanabe, Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers Anticancer Research. ,vol. 19, pp. 3249- 3252 ,(1999)
Sabine Merkelbach-Bruse, Volkmar Hans, Micaela Mathiak, Rosario Sanguedolce, Riccardo Alessandro, Josef Rüschoff, Reinhard Büttner, Farzad Houshdaran, Lucia Gullotti, Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer. Oncology Reports. ,vol. 11, pp. 839- 843 ,(2004) , 10.3892/OR.11.4.839
David Edler, Bengt Glimelius, Marja Hallström, Anders Jakobsen, Patrick G. Johnston, Inger Magnusson, Peter Ragnhammar, Henric Blomgren, Thymidylate Synthase Expression in Colorectal Cancer: A Prognostic and Predictive Marker of Benefit From Adjuvant Fluorouracil-Based Chemotherapy Journal of Clinical Oncology. ,vol. 20, pp. 1721- 1728 ,(2002) , 10.1200/JCO.2002.07.039
Nobuyuki Horie, Hideo Aiba, Katsuhiko Oguro, Hiroatsu Hojo, Keiichi Takeishi, Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase Cell Structure and Function. ,vol. 20, pp. 191- 197 ,(1995) , 10.1247/CSF.20.191
S T Pullarkat, J Stoehlmacher, V Ghaderi, Y-P Xiong, S A Ingles, A Sherrod, R Warren, D Tsao-Wei, S Groshen, H-J Lenz, Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics Journal. ,vol. 1, pp. 65- 70 ,(2001) , 10.1038/SJ.TPJ.6500012